| 1 | birth | 16,057 |
| 2 | oocytes/embryos | 5 |
| 3 | 3d-t-p | 4 |
| 4 | 4-kg | 3 |
| 5 | appropriate-for | 3 |
| 6 | birth- | 3 |
| 7 | dimetotiazine | 2 |
| 8 | insulin-processing | 2 |
| 9 | pc/gdo | 2 |
| 10 | teca/ldh | 2 |
| 11 | tenolysis | 2 |
| 12 | 0.1c | 1 |
| 13 | 1,2:5,6-di-o-isopropylidene-3-c-trifluoromethyl | 1 |
| 14 | 1,3-cl2-5-fc-2,4,6- | 1 |
| 15 | 12,815 | 1 |
| 16 | 13,158 | 1 |
| 17 | 2-acetoxyl-4,5-bis | 1 |
| 18 | 2-alkenyl-4,4-dialkyl-3,5-isoxazolidinediones | 1 |
| 19 | 3'-phosphoramidite | 1 |
| 20 | 8-bromo-3-cyano-6-fluoroquinoline-4 | 1 |
| 21 | caloric-content | 1 |
| 22 | co2-concentration | 1 |
| 23 | deliveryand | 1 |
| 24 | diagnostic-testing | 1 |
| 25 | fluidics | 1 |
| 26 | fluticasone/flunisolide | 1 |
| 27 | glyoxal- | 1 |
| 28 | h=31.71 | 1 |
| 29 | infinitive | 1 |
| 30 | label-recommended | 1 |
| 31 | lagb-induced | 1 |
| 32 | mosaicities | 1 |
| 33 | noninsured | 1 |
| 34 | ntmb | 1 |
| 35 | ogua | 1 |
| 36 | preconsumption | 1 |
| 37 | progeny/litter | 1 |
| 38 | si-groups | 1 |
| 39 | strength/body | 1 |
| 40 | tst-calculated | 1 |
| 41 | unequaled | 1 |
| 42 | virulene | 1 |
| 1 | 0.1c | 1 |
| 2 | 1,2:5,6-di-o-isopropylidene-3-c-trifluoromethyl | 1 |
| 3 | 1,3-cl2-5-fc-2,4,6- | 1 |
| 4 | 12,815 | 1 |
| 5 | 13,158 | 1 |
| 6 | 2-acetoxyl-4,5-bis | 1 |
| 7 | 2-alkenyl-4,4-dialkyl-3,5-isoxazolidinediones | 1 |
| 8 | 3'-phosphoramidite | 1 |
| 9 | 3d-t-p | 4 |
| 10 | 4-kg | 3 |
| 11 | 8-bromo-3-cyano-6-fluoroquinoline-4 | 1 |
| 12 | appropriate-for | 3 |
| 13 | birth | 16,057 |
| 14 | birth- | 3 |
| 15 | caloric-content | 1 |
| 16 | co2-concentration | 1 |
| 17 | deliveryand | 1 |
| 18 | diagnostic-testing | 1 |
| 19 | dimetotiazine | 2 |
| 20 | fluidics | 1 |
| 21 | fluticasone/flunisolide | 1 |
| 22 | glyoxal- | 1 |
| 23 | h=31.71 | 1 |
| 24 | infinitive | 1 |
| 25 | insulin-processing | 2 |
| 26 | label-recommended | 1 |
| 27 | lagb-induced | 1 |
| 28 | mosaicities | 1 |
| 29 | noninsured | 1 |
| 30 | ntmb | 1 |
| 31 | ogua | 1 |
| 32 | oocytes/embryos | 5 |
| 33 | pc/gdo | 2 |
| 34 | preconsumption | 1 |
| 35 | progeny/litter | 1 |
| 36 | si-groups | 1 |
| 37 | strength/body | 1 |
| 38 | teca/ldh | 2 |
| 39 | tenolysis | 2 |
| 40 | tst-calculated | 1 |
| 41 | unequaled | 1 |
| 42 | virulene | 1 |
| 1 | 1,3-cl2-5-fc-2,4,6- | 1 |
| 2 | birth- | 3 |
| 3 | glyoxal- | 1 |
| 4 | h=31.71 | 1 |
| 5 | 8-bromo-3-cyano-6-fluoroquinoline-4 | 1 |
| 6 | 12,815 | 1 |
| 7 | 13,158 | 1 |
| 8 | ogua | 1 |
| 9 | ntmb | 1 |
| 10 | 0.1c | 1 |
| 11 | lagb-induced | 1 |
| 12 | label-recommended | 1 |
| 13 | unequaled | 1 |
| 14 | noninsured | 1 |
| 15 | tst-calculated | 1 |
| 16 | deliveryand | 1 |
| 17 | fluticasone/flunisolide | 1 |
| 18 | virulene | 1 |
| 19 | dimetotiazine | 2 |
| 20 | 3'-phosphoramidite | 1 |
| 21 | infinitive | 1 |
| 22 | 4-kg | 3 |
| 23 | insulin-processing | 2 |
| 24 | diagnostic-testing | 1 |
| 25 | teca/ldh | 2 |
| 26 | birth | 16,057 |
| 27 | 1,2:5,6-di-o-isopropylidene-3-c-trifluoromethyl | 1 |
| 28 | co2-concentration | 1 |
| 29 | preconsumption | 1 |
| 30 | pc/gdo | 2 |
| 31 | 3d-t-p | 4 |
| 32 | progeny/litter | 1 |
| 33 | appropriate-for | 3 |
| 34 | fluidics | 1 |
| 35 | mosaicities | 1 |
| 36 | 2-alkenyl-4,4-dialkyl-3,5-isoxazolidinediones | 1 |
| 37 | 2-acetoxyl-4,5-bis | 1 |
| 38 | tenolysis | 2 |
| 39 | oocytes/embryos | 5 |
| 40 | si-groups | 1 |
| 41 | caloric-content | 1 |
| 42 | strength/body | 1 |